
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease</title>
<style>

<style>
/* ===== GENERAL LAYOUT ===== */
body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    background: linear-gradient(135deg, #eef2ff, #fafafa);
    color: #2c2c2c;
    padding: 30px;
    margin: 0;
}

/* Centered mindmap container */
.mindmap {
    max-width: 800px;
    margin: auto;
    font-size: 20px;
    line-height: 1.7;
}

/* ===== LISTS ===== */
.mindmap ul {
    margin: 0.6em 0 1em 1.5em;
    padding-left: 1.4em;
    list-style: disc;
    color: #555;
    font-size: 0.95em;
    font-weight: 400;
    line-height: 1.6;
}

.mindmap li::marker {
    color: #8b5cf6; /* accent bullet color */
}

.mindmap li {
    margin-bottom: 6px;
    padding-left: 4px;
}

/* ===== COLLAPSIBLE SECTIONS ===== */
.mindmap details {
    /* FIX: Increased border width and used a darker color */
    border-left: 5px solid #7c3aed; 
    background: #ffffff;
    margin: 8px 0;
    /* FIX: Corrected typo "20x" to "20px" */
    padding: 9px 25px; 
    border-radius: 20px;
    box-shadow: 0 4px 12px rgba(139, 92, 246, 0.1);
    transition: all 0.3s ease;
    position: relative;
}

/* Subsection (nested details) */
.mindmap details > div > details {
    margin-left: -8px;
    /* FIX: Used a darker, more saturated color for the nested border */
    border-color: #9333ea; 
    background: #faf7ff;
}

/* Subtle hover feedback */
.mindmap details:hover {
    box-shadow: 0 6px 18px rgba(139, 92, 246, 0.18);
    background: linear-gradient(135deg, #ffffff, #f5f0ff);
}

/* ===== SUMMARY HEADERS ===== */
.mindmap summary {
    cursor: pointer;
    font-size: 1.1em;
    font-weight: 600;
    list-style: none;
    position: relative;
    /* FIX: Increased padding slightly to prevent text from touching the arrow icon */
    padding-left: 24px; 
    color: #4c1d95;
    outline: none;
}

/* Custom arrow icon */
.mindmap summary::before {
    content: "â–¶";
    position: absolute;
    left: 0;
    top: 2px;
    transition: transform 0.3s ease;
    font-size: 1em;
    color: #7c3aed;
}

/* Rotated arrow when open */
.mindmap details[open] > summary::before {
    transform: rotate(90deg);
}

/* Section title emphasis */
.mindmap summary strong {
    display: block;
    font-size: 1.25em;
    color: #4c1d95;
}

.mindmap summary em {
    font-style: normal;
    color: #6b21a8;
    font-size: 0.95em;
}

/* Open section highlighting */
.mindmap details[open] > summary {
    background: #f3e8ff;
    border-radius: 8px;
    padding: 6px 10px;
}

/* Smooth fade for expanded content */
.mindmap details[open] > div {
    animation: fadeIn 0.3s ease-in;
}

/* ===== DESCRIPTION BOXES ===== */
.mindmap .desc-box {
    background: #fdfcff;
    border: 2px solid #e5d9fb;
    border-left: 4px solid #c084fc;
    padding: 6px 10px;
    margin: 12px 0 18px 0;
    border-radius: 12px;
    box-shadow: 0 1px 3px rgba(160, 104, 255, 0.05);
    transition: background 0.3s ease;
}
.mindmap .desc-box:hover {
    background: #f8f4ff;
}

/* ===== ANIMATIONS ===== */
@keyframes fadeIn {
    from { opacity: 0; transform: translateY(-3px); }
    to { opacity: 1; transform: translateY(0); }
}

/* ===== BUTTONS ===== */
button {
    background-color: #7c3aed;
    color: white;
    border: none;
    padding: 10px 16px;
    margin: 0 6px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
button:hover {
    background-color: #6b21a8;
    transform: scale(1.05);
}

/* ===== FLOATING CONTROL PANEL ===== */
#level-controls {
    position: fixed;
    bottom: 30px;
    left: 85%;
    transform: translateX(-50%);
    background: rgba(255, 255, 255, 0.05);
    padding: 10px 16px;
    border-radius: 12px;
    box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15);
    z-index: 9999;
    backdrop-filter: blur(6px);
    cursor: move;
    display: flex;
    align-items: center;
    gap: 6px;
}

/* Buttons inside the panel */
#level-controls button {
    background-color: rgba(124, 58, 237, 0.85);
    color: white;
    border: none;
    padding: 8px 14px;
    font-size: 2em;
    border-radius: 8px;
    cursor: pointer;
    transition: background 0.3s ease, transform 0.2s ease;
}
#level-controls button:hover {
    background-color: rgba(107, 33, 168, 0.95);
    transform: scale(1.05);
}

/* Search input inside panel */
#level-controls input {
    border: 1px solid #d5c4ff;
    border-radius: 8px;
    padding: 7px 10px;
    font-size: 0.95em;
    outline: none;
    width: 150px;
    transition: border-color 0.2s ease;
}
#level-controls input:focus {
    border-color: #8b5cf6;
}

/* Search count text */
#searchCount {
    margin-left: 8px;
    font-style: italic;
    color: #4c1d95;
    font-size: 0.9em;
}

/* ===== SEARCH HIGHLIGHT ===== */
mark.search-highlight {
    background-color: #fff59d;
    color: #000;
    border-radius: 3px;
    padding: 1px 3px;
}



/* ===== CLICK-TO-REVEAL: Spoiler Blur Style ===== */
.mindmap q {
    cursor: pointer;
    color: transparent;
    /* Apply a text-shadow with the same color as the text to create the blur effect */
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease;
}

.mindmap q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* Style for the revealed text */
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}




/*for full control button*/
/* ===== CLICK-TO-REVEAL: Spoiler Blur Style (with Read Mode) ===== */

/* This rule applies the blur ONLY when the mindmap is NOT in read-mode. */
.mindmap:not(.read-mode) q {
    cursor: pointer;
    color: transparent;
    text-shadow: 0 0 8px #2c2c2c; 
    user-select: none;
    transition: text-shadow 0.3s ease, color 0.3s ease;
}

.mindmap:not(.read-mode) q:hover {
    text-shadow: 0 0 4px #2c2c2c; /* Reduce blur on hover */
}

/* This combined rule handles BOTH cases for revealing text:
   1. The entire mindmap is in read-mode.
   2. An individual <q> has been clicked (in quiz mode).
*/
.mindmap.read-mode q,
.mindmap q.is-revealed {
    color: inherit;
    text-shadow: none;
    cursor: default;
    user-select: text;
}


</style>

</style>
</head>
<body>

<!-- Updated Controls -->
<div id="level-controls" onmousedown="dragElement(this)">
    <button onclick="zoomIn()">+</button>
    <button onclick="zoomOut()">-</button>
    <button onclick="resetView()">=</button>
    <!-- NEW: READ MODE TOGGLE BUTTON -->
    <button onclick="toggleReadMode()">Q/R</button>
</div>

<div class="mindmap">

    <div class="mindmap">
        
        <details>
            <summary><strong>AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease</strong></summary>
            <div>
                <ul><li>- Journal: Clinical Gastroenterology and Hepatology</li><li>- Publication Date: 2024;22:1790â€“1795</li><li>- Link: https://doi.org/10.1016/j.cgh.2024.04.039</li></ul>
                
        <details>
            <summary><strong>ðŸ’¡ Knowledge Test</strong></summary>
            <div>
                <ul><li>- In postoperative Crohn's disease, what bowel wall thickness (BWT) in the neo-terminal ileum suggests recurrence?</li><li>- For Ulcerative Colitis patients on tofacitinib, what absolute BWT is 100% specific for week 8 endoscopic remission?</li><li>- In hospitalized acute severe UC, what percentage reduction in BWT within 48 hours of IV steroids predicts a favorable response?</li><li>- In Crohn's disease patients, a post-treatment BWT reduction of at least what percentage makes them 10 times more likely to achieve endoscopic response?</li><li>- What is the negative predictive value of a lack of sonographic response at week 4 for predicting poor week 48 endoscopic response in CD patients on ustekinumab?</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>IBD Overview & Monitoring Challenges</strong></summary>
            <div>
                <ul><li>- Inflammatory Bowel Disease (IBD), including Crohnâ€™s disease (CD) and ulcerative colitis (UC), is a chronic GI inflammatory disorder.</li><li>- Leads to significant morbidity: <b>bowel obstructions, fistulas, and cancer</b>.</li><li>- Primary treatment goal is to reverse endoscopically visible inflammation to achieve long-term clinical remission.</li></ul>
                
        <details>
            <summary><strong>Limitations of Current Monitoring</strong></summary>
            <div>
                <ul><li>- Clinical remission does not always correlate with endoscopic healing.</li><li>- Frequent endoscopies are burdensome for patients.</li><li>- Biomarkers like fecal calprotectin (FC) and C-reactive protein can be challenging to access.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Emergence of Intestinal Ultrasound (IUS)</strong></summary>
            <div>
                <ul><li>- IUS is a valuable tool for objectively assessing and monitoring IBD activity.</li><li>- It offers a <b>noninvasive, radiation-free</b> alternative to endoscopy and other imaging.</li><li>- Provides real-time, high-resolution examination of the bowel wall, mesentery, and adjacent structures.</li><li>- Facilitates <u>point-of-care</u> decisions and timely treatment adjustments.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Intestinal Ultrasound (IUS) Technique</strong></summary>
            <div>
                <ul><li>- IUS is a transabdominal examination of the colon and small intestine.</li><li>- It is performed <u>without</u> bowel preparation, fasting, or intravenous/oral contrast.</li></ul>
                
        <details>
            <summary><strong>Equipment</strong></summary>
            <div>
                <ul><li>- High-resolution ultrasound system.</li><li>- Low-frequency <b>convex</b> transducer for initial global assessment.</li><li>- High-frequency <b>linear</b> transducer for detailed disease activity evaluation.</li></ul>
                
        <details>
            <summary><strong>Special Considerations</strong></summary>
            <div>
                <ul><li>- In patients with a small body habitus and in children, a linear transducer alone is often adequate.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Key Measures of Disease Activity</strong></summary>
            <div>
                <ul><li>- Primary measures: <b>Bowel Wall Thickness (BWT)</b> and <b>Bowel Wall Hyperemia</b> (using color Doppler signal).</li><li>- Indicators of more severe disease include inflammatory mesenteric fat, loss of bowel wall stratification, and surrounding lymphadenopathy.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Identifiable Complications</strong></summary>
            <div>
                <ul><li>- Strictures</li><li>- Fistulae</li><li>- Sinus tracts</li><li>- Phlegmons</li><li>- Abscesses</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>IUS vs. Alternative Modalities</strong></summary>
            <div>
                <ul><li>- IUS, performed by well-trained practitioners, is comparable in accuracy to MRE and CTE for defining disease activity of the ileum (See Table 1).</li></ul>
                
        <details>
            <summary><strong>vs. MRE & CTE</strong></summary>
            <div>
                <ul><li>- MRE and CTE are the cross-sectional imaging modalities of choice for small intestinal CD.</li><li>- IUS has practical advantages: <b>no contrast</b>, <b>no radiation</b> (vs. CTE), and can be performed in-clinic for real-time decision making.</li></ul>
                
        <details>
            <summary><strong>Inter-observer Reliability</strong></summary>
            <div>
                <ul><li>- IUS demonstrates moderate to excellent inter-observer reliability.</li><li>- A sub-study showed higher agreement for serial IUS compared to serial MRE.</li><li>- IUS agreement: <q>82%</q> (kappa 0.61-0.64).</li><li>- MRE agreement: <q>69%</q> (kappa 0.36-0.56).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Complication Detection</strong></summary>
            <div>
                <ul><li>- A meta-analysis shows that IUS, MRE, and CTE have <b>comparable accuracy</b> for detecting IBD-related complications like fistula, stricture, and abscesses.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>vs. Endoscopy (Ileocolonoscopy & VCE)</strong></summary>
            <div>
                <ul><li>- <u>Endoscopy Advantages</u>: Direct mucosal visualization, ability to perform biopsies or dilations.</li><li>- <u>Endoscopy Disadvantages</u>: More time-intensive, expensive, often requires sedation, and examination is limited to the terminal ileum and colon.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Clinical Applications of IUS</strong></summary>
            <div>
                <ul><li>- IUS has multiple roles in clinical care, from screening to monitoring treatment response.</li></ul>
                
        <details>
            <summary><strong>Screening & Diagnosis</strong></summary>
            <div>
                <ul><li>- Can be used as a screening tool, similar to FC, to rule out IBD.</li><li>- Positive findings (increased BWT or hyperemia) can help expedite ileocolonoscopy for diagnosis.</li></ul>
                
        <details>
            <summary><strong>Postoperative CD Recurrence</strong></summary>
            <div>
                <ul><li>- IUS showing BWT <q><b>â‰¥ 3 mm</b></q> in the neo-terminal ileum or adjacent colon combined with an FC <q><b>â‰¥ 50 ug/g</b></q> detects CD recurrence.</li><li>- Positive Predictive Value: <q>74%</q>.</li><li>- Negative Predictive Value: <q>71%</q>.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Monitoring Disease Activity</strong></summary>
            <div>
                <ul><li>- IUS can facilitate timely treatment adjustments by objectively assessing response.</li></ul>
                
        <details>
            <summary><strong>Crohn's Disease (CD)</strong></summary>
            <div>
                <ul><li>- Treatment response on IUS can be identified within <q><b>3 months</b></q> of starting biologic therapy.</li><li>- <u>Treatment failure prediction</u>: Patients with a higher baseline BWT are <q>42% less likely</q> to achieve transmural healing at 1 year.</li></ul>
                
        <details>
            <summary><strong>Ustekinumab Trial Data</strong></summary>
            <div>
                <ul><li>- At 48 weeks, sonographic response (â‰¥25% BWT reduction) was seen in <q><b>46.3%</b></q> and transmural healing in <q><b>24.1%</b></q>.</li><li>- <u>Prognostic Value</u>: Lack of sonographic response at week 4 predicted poor week 48 endoscopic response with a negative predictive value of <q><b>73%</b></q>.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Anti-TNF Study Data</strong></summary>
            <div>
                <ul><li>- Patients with a <q><b>â‰¥ 18%</b></q> reduction in BWT at 4-8 weeks post-treatment were <q><b>10 times</b></q> as likely to achieve a week 12-32 endoscopic response.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Ulcerative Colitis (UC)</strong></summary>
            <div>
                <ul><li>- Normalization of BWT can be visualized as early as <q><b>2 weeks</b></q> after a treatment change.</li></ul>
                
        <details>
            <summary><strong>Tofacitinib Study Data</strong></summary>
            <div>
                <ul><li>- An absolute BWT of <q><b><2.8 mm</b></q> was predictive of week 8 endoscopic remission (Sensitivity 73%, <u>Specificity 100%</u>).</li><li>- A <q><b>â‰¥ 32%</b></q> reduction in BWT also predicted week 8 endoscopic response (Sensitivity 71%, Specificity 90%).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Acute Severe UC (Hospitalized)</strong></summary>
            <div>
                <ul><li>- A <q><b>â‰¥ 20%</b></q> reduction in BWT within 48Â±24 hours after IV corticosteroid initiation predicted better outcomes.</li><li>- More likely to achieve endoscopic response (OR: <q>22.6</q>).</li><li>- More likely to avoid rescue biologic therapy (OR: <q>6.3</q>).</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Special Populations</strong></summary>
            <div>
                <ul><li>- IUS is particularly valuable in patient groups where other modalities are challenging.</li></ul>
                
        <details>
            <summary><strong>Pregnant Patients</strong></summary>
            <div>
                <ul><li>- Effective for recognizing flares and monitoring treatment response.</li><li>- Avoids radiation from CTE and sedation for ileocolonoscopy.</li><li>- Shows a sensitivity of <q>84%</q> and specificity of <q>98%</q> correlating with clinical activity and FC.</li><li>- The colon and terminal ileum can be visualized in up to <q><b>92%</b></q> of cases in the third trimester.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Patients with Serious Comorbidities</strong></summary>
            <div>
                <ul><li>- Plays a key role for patients with conditions like <b>renal failure</b> who are high-risk for sedation or cannot receive IV contrast.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Obese Patients</strong></summary>
            <div>
                <ul><li>- While image quality may be limited, a recent study showed <b>no significant difference</b> in IUS findings by weight.</li><li>- Obesity does not preclude the use of IUS.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Patient Experience & System-Level Benefits</strong></summary>
            <div>
                <ul><li>- IUS offers a more patient-centered approach and can address systemic issues in healthcare.</li></ul>
                
        <details>
            <summary><strong>Patient-Centered Care</strong></summary>
            <div>
                <ul><li>- Qualitative research shows patients prefer noninvasive monitoring options like IUS.</li><li>- Patients receiving IUS-driven care reported more confidence in making informed decisions about their disease management.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Diversity, Equity, and Inclusion</strong></summary>
            <div>
                <ul><li>- Point-of-care IUS can improve access for patients in <b>rural and underserved areas</b>.</li><li>- Helps overcome barriers such as scheduling, finding dependent care, or travel for CTE, MRE, or ileocolonoscopy.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Environmental Sustainability</strong></summary>
            <div>
                <ul><li>- IUS requires fewer plastic and paper supplies compared to colonoscopy or MRE.</li><li>- Use of non-reusable plastic is limited to gel bottles, reducing healthcare-related waste.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>IUS Training & Implementation</strong></summary>
            <div>
                <ul><li>- Integrating IUS into clinical practice requires careful consideration of equipment, workflow, and training.</li></ul>
                
        <details>
            <summary><strong>Equipment & Image Storage</strong></summary>
            <div>
                <ul><li>- System choice depends on clinical need, budget, and portability (full-scale vs. portable/hand-held).</li><li>- Image storage options include local hard drives, institutional servers, or cloud-based solutions (must be HIPAA compliant).</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Clinical Workflow Models</strong></summary>
            <div>
                <ul><li>- <b>Consecutive appointments</b>: IUS performed just before a clinic visit.</li><li>- <b>Integrated visit</b>: IUS performed by the clinician during the visit.</li><li>- <b>Standalone IUS clinic</b>: Patients are referred by other healthcare professionals.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Billing</strong></summary>
            <div>
                <ul><li>- Specific Current Procedural Terminology (CPT) codes for IUS are not yet available.</li><li>- Other codes, such as <q><b>76705</b></q> (limited abdominal ultrasound), can be used.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Training & Certification</strong></summary>
            <div>
                <ul><li>- There is no official United States-based certification for gastroenterologists yet.</li><li>- The International Bowel Ultrasound Group (IBUS) offers a comprehensive training and certification program.</li></ul>
                
        <details>
            <summary><strong>IBUS Certification Process</strong></summary>
            <div>
                <ul><li>- <b>Module 1</b>: Intensive introductory course with fundamental knowledge and hands-on experience.</li><li>- <b>Module 2</b>: Hands-on training with at least <q><b>40 patients</b></q> at a certified IBUS training center.</li><li>- <b>Module 3</b>: Advanced workshop and a final exam.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Limitations of IUS</strong></summary>
            <div>
                <ul><li>- Despite its versatility, IUS has several limitations.</li></ul>
                
        <details>
            <summary><strong>Technical Limitations</strong></summary>
            <div>
                <ul><li>- Precise measurement of disease length is difficult in extensive small bowel CD; MRE is better for this.</li><li>- Overlying bowel gas may obscure <b>proximal (duodenal) disease</b>.</li><li>- Rectal disease may be difficult to visualize without a distended bladder.</li></ul>
                
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Clinical Limitations</strong></summary>
            <div>
                <ul><li>- IUS is <u>not an advised modality</u> for <b>dysplasia surveillance</b>.</li><li>- Endoscopy or flexible sigmoidoscopy remains the most reliable method for assessing mucosal disease in the duodenum/rectum and for dysplasia screening.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
        <details>
            <summary><strong>Conclusions & Future Directions</strong></summary>
            <div>
                <ul><li>- IUS has the potential to transform the diagnosis and monitoring of IBD.</li><li>- It objectively identifies treatment response, supporting a <b>treat-to-target</b> approach.</li><li>- The value of IUS is comparable to established modalities like MRE and CTE.</li></ul>
                
        <details>
            <summary><strong>Future Goals</strong></summary>
            <div>
                <ul><li>- Current efforts focus on training gastroenterologists and Advanced Practice Providers to increase adoption.</li><li>- A key future goal is to incorporate <b>transmural healing</b> as an endpoint for remission in IBD clinical trials.</li></ul>
                
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
            </div>
        </details>
        <br>
        
    </div>
    
</div>

<br>
<br>
<br>
<br>
<br>


<script>
// --- State Management for Expansion Level ---
let currentLevel = 1; 
const maxLevel = 10;
const minLevel = 1;

// --- Core Function to Set Mindmap Expansion ---
function setMindmapLevel(level) {
    const allDetails = document.querySelectorAll('.mindmap details');
    allDetails.forEach(detail => detail.removeAttribute('open'));
    allDetails.forEach(detail => {
        let depth = 0;
        let parent = detail.parentElement;
        while (parent && parent.tagName !== 'BODY') {
            if (parent.tagName === 'DETAILS') {
                depth++;
            }
            parent = parent.parentElement;
        }
        if (depth < level) {
            detail.setAttribute('open', '');
        }
    });
}

// --- Control Functions ---
function zoomIn() {
    if (currentLevel < maxLevel) {
        currentLevel++;
        setMindmapLevel(currentLevel);
    }
}

function zoomOut() {
    if (currentLevel > minLevel) {
        currentLevel--;
        setMindmapLevel(currentLevel);
    }
}

function resetView() {
    currentLevel = minLevel;
    setMindmapLevel(currentLevel);
}


// --- NEW: Function to Toggle Read/Quiz Mode ---
function toggleReadMode() {
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.classList.toggle('read-mode');
    }
}

// --- Draggable Controls ---
function dragElement(elmnt) {
    let pos1 = 0, pos2 = 0, pos3 = 0, pos4 = 0;
    const onMouseDown = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos3 = e.clientX;
        pos4 = e.clientY;
        document.onmouseup = closeDragElement;
        document.onmousemove = elementDrag;
    };
    const elementDrag = (e) => {
        e = e || window.event;
        e.preventDefault();
        pos1 = pos3 - e.clientX;
        pos2 = pos4 - e.clientY;
        pos3 = e.clientX;
        pos4 = e.clientY;
        elmnt.style.top = (elmnt.offsetTop - pos2) + "px";
        elmnt.style.left = (elmnt.offsetLeft - pos1) + "px";
        elmnt.style.transform = "none";
        elmnt.style.bottom = "auto";
    };
    const closeDragElement = () => {
        document.onmouseup = null;
        document.onmousemove = null;
    };
    if (document.getElementById(elmnt.id)) {
        document.getElementById(elmnt.id).onmousedown = onMouseDown;
    } else {
        elmnt.onmousedown = onMouseDown;
    }
}




// --- Initial Setup ---
window.addEventListener('DOMContentLoaded', () => {
    // Set the initial mindmap view
    setMindmapLevel(currentLevel);

    // Get the draggable controls element
    const controls = document.getElementById('level-controls');
    if (controls) {
        dragElement(controls);
    }

    // --- CORRECTED & IMPROVED: Setup for Click-to-Reveal ---
    const mindmapContainer = document.querySelector('.mindmap');
    if (mindmapContainer) {
        mindmapContainer.addEventListener('click', function(event) {
            // Use .closest() to find the nearest parent <q> tag.
            // This is more robust than checking event.target.tagName.
            const quoteElement = event.target.closest('q');
            
            if (quoteElement) {
                // Add the 'is-revealed' class to show the text
                quoteElement.classList.add('is-revealed');
            }
        });
    }
});
</script>

</body>
</html>
